Sort   by:  
 Page size 
UnknownCilengitide: a prototypic integrin inhibitor for the treatment of glioblastoma and other malignancies.
Not available
S-EPMC3411133 | biostudies-literature
UnknownBibliometric evaluation of research trends and hotspots concerning the interaction between immune checkpoint inhibitors and glioma.
Not available
S-EPMC12644291 | biostudies-literature
UnknownMeeting the Needs of Emerging Adults With Type 1 Diabetes Living in a Rural Area With Mobile Health Interventions: Focus Group Study.
Not available
S-EPMC11339569 | biostudies-literature
UnknownImmunologic escape after prolonged progression-free survival with epidermal growth factor receptor variant III peptide vaccination in patients with newly diagnosed glioblastoma.
Not available
S-EPMC3020702 | biostudies-literature
UnknownMulticenter phase II study of rituximab and temozolomide in recurrent primary central nervous system lymphoma.
Not available
S-EPMC4802006 | biostudies-literature
UnknownTrotabresib, an oral potent bromodomain and extraterminal inhibitor, in patients with high-grade gliomas: A phase I, "window-of-opportunity" study.
Not available
S-EPMC10237409 | biostudies-literature
UnknownLactate dehydrogenase expression modulates longevity and neurodegeneration in Drosophila melanogaster.
Not available
S-EPMC7346061 | biostudies-literature
UnknownFBN1 contributing to familial congenital diaphragmatic hernia.
Not available
S-EPMC4522925 | biostudies-literature
UnknownPhase II trial of temozolomide plus o6-benzylguanine in adults with recurrent, temozolomide-resistant malignant glioma.
Not available
S-EPMC2667825 | biostudies-literature
UnknownPhase 0 and window of opportunity clinical trial design in neuro-oncology: a RANO review.
Not available
S-EPMC7690357 | biostudies-literature
Sort   by:  
 Page size